Svetlana I. Nareiko

Clinical and functional rationale for the use of non-pharmacological treatment in patients with visual impairments after stroke: a single-center controlled trial

INTRODUCTION. Each year, over 12 million new stroke cases are reported globally, with up to 50 % of survivors experiencing persistent neurological deficits. The most common among these deficits is post-stroke spasticity. The incidence of spasticity ranges from 20 to 40 % during the early rehabilitation period, and incr...